Stanley Laman Group, Ltd. Danaher Corp Transaction History

Stanley Laman Group, Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$233.08 - $265.59 $5,360 - $6,108	23 Added 2.42%	974 $241,000
Q2 2023 Aug 08, 2023	BUY	$224.99 - $256.14 $674 - $768	3 Added 0.32%	951 $228,000
Q1 2023 Apr 17, 2023	BUY	$239.75 - $277.0 $227,283 - $262,596	948 New	948 $238,000
Q3 2020 Oct 20, 2020	SELL	$177.16 - $215.33 $6.73 Million - $8.18 Million	-37,972 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$128.7 - $176.83 $12,741 - $17,506	99 Added 0.26%	37,972 $6.72 Million
Q1 2020 May 12, 2020	SELL	$121.39 - $169.05 $359,193 - $500,218	-2,959 Reduced 7.25%	37,873 $5.24 Million
Q4 2019 Feb 04, 2020	SELL	$133.47 - $153.48 $56,057 - $64,461	-420 Reduced 1.02%	40,832 $6.27 Million
Q3 2019 Nov 08, 2019	SELL	$135.4 - $146.47 $102,768 - $111,170	-759 Reduced 1.81%	41,252 $5.96 Million
Q2 2019 Aug 01, 2019	SELL	$124.88 - $143.73 $36,839 - $42,400	-295 Reduced 0.7%	42,011 $6 Million
Q1 2019 May 10, 2019	SELL	$97.62 - $132.29 $25,576 - $34,659	-262 Reduced 0.62%	42,306 $5.59 Million
Q4 2018 Feb 07, 2019	BUY	$94.85 - $109.54 $4.04 Million - $4.66 Million	42,568 New	42,568 $4.39 Million

2,498

551M

7.12M

4.44M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $148B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.